The investment seeks long-term capital appreciation... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SDP | 22.89 | 0.13 | +0.58% |
| ProShares UltraShort Utilities (SDP) | |||
| FSTA | 57.90 | 0.10 | +0.17% |
| Fidelity MSCI Consumer Staples Index ETF (FSTA) | |||
| XSEP | 45.14 | -0.09 | -0.19% |
| FT Vest U.S. Equity Enhance & Moderate Buffer ETF - September (XSEP) | |||
| BBC | 44.88 | -0.11 | -0.25% |
| Virtus Biotech Clinical Trials ETF (BBC) | |||
| BUFP | 32.63 | -0.10 | -0.31% |
| PGIM Laddered S&P 500 Buffer 12 ETF (BUFP) | |||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BUFP | 32.63 | -0.10 | -0.31% |
| PGIM Laddered S&P 500 Buffer 12 ETF (BUFP) | |||
| BBC | 44.88 | -0.11 | -0.25% |
| Virtus Biotech Clinical Trials ETF (BBC) | |||
| XSEP | 45.14 | -0.09 | -0.19% |
| FT Vest U.S. Equity Enhance & Moderate Buffer ETF - September (XSEP) | |||
| FSTA | 57.90 | 0.10 | +0.17% |
| Fidelity MSCI Consumer Staples Index ETF (FSTA) | |||
| SDP | 22.89 | 0.13 | +0.58% |
| ProShares UltraShort Utilities (SDP) | |||
A.I.dvisor indicates that over the last year, BCUS has been closely correlated with VTI. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if BCUS jumps, then VTI could also see price increases.
| Ticker / NAME | Correlation To BCUS | 1D Price Change % | ||
|---|---|---|---|---|
| BCUS | 100% | -0.55% | ||
| VTI - BCUS | 81% Closely correlated | -0.36% | ||
| SPY - BCUS | 79% Closely correlated | -0.37% | ||
| IVV - BCUS | 79% Closely correlated | -0.35% | ||
| VOO - BCUS | 78% Closely correlated | -0.34% | ||
| VIG - BCUS | 63% Loosely correlated | +0.26% |
The RSI Oscillator for BCUS moved out of oversold territory on November 06, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 9 similar instances when the indicator left oversold territory. In 9 of the 9 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 34 of 38 cases where BCUS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on BCUS as a result. In 41 of 49 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for BCUS just turned positive on November 09, 2026. Looking at past instances where BCUS's MACD turned positive, the stock continued to rise in 26 of 33 cases over the following month. The odds of a continued upward trend are 79%.
Following a +6.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where BCUS advanced for three days, in 155 of 199 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
BCUS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The 50-day moving average for BCUS moved below the 200-day moving average on October 22, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BCUS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
The Aroon Indicator for BCUS entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.